Login to Your Account

Up to $1.4B in Milestones

Molecular Partners Gets $62.5M as Allergan Repeats on Darpins

By Cormac Sheridan
Staff Writer

Wednesday, August 22, 2012

Molecular Partners AG is banking $62.5 million up front and could receive up to $1.4 billion more in development, regulatory and commercial milestones in its second ophthalmology deal with Allergan Inc.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription